Journal of Diagnostics Concepts & Practice ›› 2021, Vol. 20 ›› Issue (03): 290-293.doi: 10.16150/j.1671-2870.2021.03.011
• Review article • Previous Articles Next Articles
Received:2021-01-20
Online:2021-06-25
Published:2022-06-28
CLC Number:
| [1] |
Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development[J]. Cell, 2019, 176(6):1248-1264.
doi: 10.1016/j.cell.2019.01.021 URL |
| [2] |
Song P, Wang J, Bucan K, et al. National and subnatio-nal prevalence and burden of glaucoma in China: a systematic analysis[J]. J Glob Health, 2017, 7(2):020705.
doi: 10.7189/jogh.07.020705 URL |
| [3] |
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review[J]. JAMA, 2014, 311(18):1901-1911.
doi: 10.1001/jama.2014.3192 pmid: 24825645 |
| [4] | Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy[J]. Nat Rev Drug Discov, 2016, 15(6):385-403. |
| [5] | Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis[J]. Rom J Morphol Embryol, 2018, 59(2):455-467. |
| [6] |
Alkharsah KR. VEGF upregulation in viral infections and its possible therapeutic implications[J]. Int J Mol Sci, 2018, 19(6):1642.
doi: 10.3390/ijms19061642 URL |
| [7] |
Chen R, Lee C, Lin X, et al. Novel function of VEGF-B as an antioxidant and therapeutic implications[J]. Pharmacol Res, 2019, 143:33-39.
doi: 10.1016/j.phrs.2019.03.002 URL |
| [8] |
van Bergen T, Etienne I, Cunningham F, et al. The role of placental growth factor(PlGF) and its receptor system in retinal vascular diseases[J]. Prog Retin Eye Res, 2019, 69:116-136.
doi: S1350-9462(18)30060-0 pmid: 30385175 |
| [9] |
Wang J, Huang Y, Zhang J, et al. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis[J]. Clin Chim Acta, 2016, 461:165-171.
doi: 10.1016/j.cca.2016.08.008 URL |
| [10] |
Tian YI, Zhang X, Torrejon K, et al. A bioengineering approach to Schlemm′s canal-like stem cell differentiation for in vitro glaucoma drug screening[J]. Acta Biomater, 2020, 105:203-213.
doi: 10.1016/j.actbio.2020.01.033 URL |
| [11] |
Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-screening, diagnosis, and management: a review[J]. JAMA, 2021, 325(2):164-174.
doi: 10.1001/jama.2020.21899 URL |
| [12] | 汤加, 陈有信. 血管内皮生长因子的神经保护作用[J]. 中华实验眼科杂志, 2020, 38(1): 64-67. |
| [13] | Lange C, Storkebaum E, de Almodóvar CR, et al. Vascular endothelial growth factor: a neurovascular target in neurological diseases[J]. Nat Rev Neurol, 2016, 12(8):439-454. |
| [14] |
Cattin AL, Burden JJ, Van Emmenis L, et al. Macrophage-induced blood vessels guide schwann cell-mediated regeneration of peripheral nerves[J]. Cell, 2015, 162(5):1127-1139.
doi: 10.1016/j.cell.2015.07.021 URL |
| [15] | Po$\grave{\text z}$arowska D, Po$\grave{\text z}$arowski P, The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy[J]. Cent Eur J Immunol, 2016, 41(3):311-316. |
| [16] |
Sun C, Zhang H, Jiang J, et al. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy[J]. Int Ophthalmol, 2020, 40(2):467-475.
doi: 10.1007/s10792-019-01207-4 URL |
| [17] | 张水华, 曲毅. 血管内皮生长因子B对小鼠视神经保护作用的研究[J]. 中华眼科杂志, 2009, 45(1):38-42. |
| [18] |
Shen J, Xiao R, Bair J, et al. Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study[J]. Cell Death Dis, 2018, 9(10):1018.
doi: 10.1038/s41419-018-1049-0 URL |
| [19] |
Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury[J]. Am J Pathol, 2007, 171(1):53-67.
pmid: 17591953 |
| [20] | Fahy ET, Chrysostomou V, Crowston JG. Mini-review: impaired axonal transport and glaucoma[J]. Curr Eye Res, 2016, 41(3):273-283. |
| [21] | 朱轶冰, 陆佩华, 盛祖杭. AD发病机制的新探索:轴浆运输障碍假说[J]. 生理科学进展, 2008, 39(1):5-9. |
| [22] | 党鸿辛, 辛晓蓉. 青光眼视神经损伤机制的研究进展[J]. 眼科新进展, 2016, 36(7):680-683. |
| [23] |
Foxton R, Osborne A, Martin KR, et al. Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism[J]. Cell Death Dis, 2016, 7(5):e2212.
doi: 10.1038/cddis.2016.110 URL |
| [24] |
Yang P, Sun X, Kou ZW, et al. VEGF axonal transport dependent on kinesin-1B and microtubules dynamics[J]. Front Mol Neurosci, 2017, 10:424.
doi: 10.3389/fnmol.2017.00424 URL |
| [25] |
Dapper JD, Crish SD, Pang IH, et al. Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy[J]. Neurobiol Dis, 2013, 59:26-37.
doi: 10.1016/j.nbd.2013.07.001 pmid: 23859799 |
| [26] |
Tsai T, Grotegut P, Reinehr S, et al. Role of heat shock proteins in glaucoma[J]. Int J Mol Sci, 2019, 20(20):5160.
doi: 10.3390/ijms20205160 URL |
| [27] | Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling[J]. Nat Rev Mol Cell Biol, 2016, 17(10):611-625. |
| [28] |
Foxton RH, Finkelstein A, Vijay S, et al. VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma[J]. Am J Pathol, 2013, 182(4):1379-1390.
doi: 10.1016/j.ajpath.2012.12.032 URL |
| [29] |
Almasieh M, Wilson AM, Morquette B, et al. The mole-cular basis of retinal ganglion cell death in glaucoma[J]. Prog Retin Eye Res, 2012, 31(2):152-181.
doi: 10.1016/j.preteyeres.2011.11.002 URL |
| [30] | Lawler T, Liu Y, Christensen K, et al. Dietary antioxidants, macular pigment, and glaucomatous neurodegene-ration: a review of the evidence[J]. Nutrients, 2019, 1(5):1002. |
| [31] | Li Y, Zhang F, Nagai N, et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats[J]. J Clin Invest, 2008, 118(3):913-923. |
| [32] |
Shukla S, Saxena S, Singh BK, et al. BH3-only protein BIM: an emerging target in chemotherapy[J]. Eur J Cell Biol, 2017, 96(8):728-738.
doi: 10.1016/j.ejcb.2017.09.002 URL |
| [33] |
Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases[J]. Prog Retin Eye Res, 2015, 49:67-81.
doi: 10.1016/j.preteyeres.2015.06.002 pmid: 26113211 |
| [34] |
Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease[J]. Annu Rev Vis Sci, 2018, 4:45-77.
doi: 10.1146/annurev-vision-091517-034425 pmid: 29852094 |
| [35] |
Galán-Ganga M, García-YagüeáJ, Lastres-Becker I. Role of MSK1 in the induction of NF-κB by the chemokine CX3CL1 in microglial cells[J]. Cell Mol Neurobiol, 2019, 39(3):331-340.
doi: 10.1007/s10571-019-00664-w pmid: 30830503 |
| [36] |
Perbal A. 8th international workshop on the CCN family of genes-Nice November 3-8, 2015[J]. J Cell Commun Signal, 2016, 10(1):87-101.
doi: 10.1007/s12079-016-0319-9 pmid: 27074941 |
| [37] |
Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites[J]. Nature, 2018, 557(7707):724-728.
doi: 10.1038/s41586-018-0119-x URL |
| [38] |
Hoguet A, Chen PP, Junk AK, et al. The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: a report by the American Academy of Ophthalmology[J]. Ophthalmology, 2019, 126(4):611-622.
doi: 10.1016/j.ophtha.2018.11.019 URL |
| No related articles found! |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
